HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G May Be Simpler, More Efficient, But Investors Anxious For Growth

This article was originally published in The Rose Sheet

Executive Summary

Firm has largely completed its portfolio trimming and restructuring and continues to see productivity gains, but organic growth fell short of many investors' expectations in fiscal 2015, inching up 1% for the year. During a fiscal 2015 full-year earnings call July 30, analysts questioned P&G's strategy, expected timing for improvements and whether recent divestitures will have the impact the firm foresees.

You may also be interested in...



Moeller Takes P&G Reins With 33-Year Grasp Of Products, Planning And Footprint

Jon Moeller appointed to succeed David Taylor, at the helm for almost six years and remaining as executive chairman, a day before P&G releases FY21 full-year and Q4 results.

P&G’s Q3: Negative Pricing, ‘Change In Tone’ Have Analysts Spooked

Firm’s slowing organic growth and negative pricing impacts in the third quarter reflect much-talked-about pressures in health and beauty care. However, the scope of the challenges is becoming clearer, and analysts are questioning whether P&G’s “not business as usual” response will be enough.

P&G Talks Digital, Shave Biz Strategy In Light Of Unilever’s DSC Buy

Many emerging e-commerce brands may merely be flash-in-the-pan phenomena, but P&G is investing significantly in e-commerce and digital marketing to “win mobile back,” according to CEO David Taylor. The firm also will continue to strengthen the mid and value tiers of its shave business, he said during a Q4 earnings call in which Unilever’s Dollar Shave Club acquisition was on a number of analysts’ minds.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019597

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel